ArticleInternational journal of clinical and experimental medicine2015

Knockdown of CIP2A sensitizes ovarian cancer cells to cisplatin: an in vitro study.

Xiaoli Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.